Close Menu

NEW YORK (GenomeWeb) – Gene editing technology company Inscripta said today that it plans to acquire Solana Biosciences, a life sciences company founded in 2017 by former Illumina employees.

The acquisition will help accelerate the commercialization of Inscripta's gene editing tools by assembling a life science product development and manufacturing pipeline for precision gene editing, the firm said. Terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.